Dr Reddy's Lab shares hit one-year low; down nearly 5%
Shares of Dr Reddy's Laboratories today fell by nearly 5 per cent after the company received 13 observations from the US health regulator for its formulation manufacturing facility at Duwada, Visakhapatnam.
Shares of Dr Reddy's Laboratories
today fell by nearly 5 per cent after the company received 13
observations from the US health regulator for its formulation
manufacturing facility at Duwada, Visakhapatnam.
The stock went down by 4.6 per cent to Rs 2,720 -- its
52-week low level -- on BSE.
On NSE, it slipped 4.64 per cent to hit its one-year low
of Rs 2,714.50.
The stock was the worst performer among the bluechips on
both the Sensex and Nifty
"The audit of company's formulation manufacturing facility
at Duwada, Visakhapatnam, by the USFDA, has been completed on
March 8, 2017. The company has been issued Form 483 with 13
observations, which the company is addressing," Dr Reddy's
Laboratories said in a BSE filing.
The firm, however, did not specify the observations.
(This article has not been edited by DNA's editorial team and is auto-generated from an agency feed.)